Skip to main content
Veterinary Medicines

Nalgosed, 10mg/ml, Solution for injection

Authorised
  • Butorphanol

Product identification

Medicine name:
Nalgosed, 10mg/ml, Solution for injection
NALGOSED 10 mg/ml injekcinis tirpalas
Active substance:
  • Butorphanol
Target species:
  • Cat
  • Dog
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Butorphanol
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
    • Dog
  • Intravenous use
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cat
    • Dog
  • Subcutaneous use
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AF01
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Glass Vial 1 x 10.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/18/2466/001
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0142/001
Concerned member states:
  • Bulgaria
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia

Documents

RV2466.pdf

Lithuanian (PDF)
Published on: 25/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."